Insider · CIK 0001917503
Abinand Rangesh
Files at TGEN (TECOGEN INC.). First filing Mar 23, 2026, latest Mar 23, 2026.
In brief
Abinand Rangesh files SEC Form 4 as CEO and director at TGEN (TECOGEN INC.). Since Mar 23, 2026, Abinand Rangesh has reported 1 open-market buy worth $6,894 and 0 open-market sells worth $0, the latest filed on Mar 23, 2026.
A track record needs three past buys with six months of prices behind them; Abinand Rangesh has 0, so none is measured yet.
The newest scored trade: bought $6,894 of TGEN on Mar 20, 2026, filed Mar 23, 2026, scored 48 (moderate). In the last 12 months: 1 buy worth $6,894 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TGEN: TECOGEN INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | TECOGEN INC. | $6,894 3,000 shares | +5% | +22% from low-82% from high |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | TGEN TECOGEN INC. | AGrant or award Common Stock | +174,081 | $0.00 | $0 | 241,274 | 35 d ago |
| Jun 26, 2026 | TGEN TECOGEN INC. | AGrant or award Common Stock | +174,081 | - | - | 174,081 | Jun 30, 2026 |
| Jun 26, 2026 | TGEN TECOGEN INC. | AGrant or award Stock Option (Right to Buy)derivative | +26,041 | $5.17 | $135k | 26,041 | Jun 30, 2026 |
| Mar 20, 2026 | TGEN TECOGEN INC. | POpen-market purchase Common Stock | +3,000 | $2.30 | $6,894 | 67,193 | Mar 23, 2026 |
| Jul 24, 2025 | TGEN TECOGEN INC. | AGrant or award Common Stock | +53,892 | $0.00 | $0 | 64,193 | Jul 28, 2025 |
| Jul 24, 2025 | TGEN TECOGEN INC. | AGrant or award Stock Option (Right to Buy)derivative | +24,075 | $8.35 | $201k | 294,075 | Jul 28, 2025 |
| Jul 24, 2025 | TGEN TECOGEN INC. | AGrant or award Stock Option (Right to Buy)derivative | +12,048 | $8.35 | $101k | 306,123 | Jul 28, 2025 |
Questions about Abinand Rangesh
Answered from the filings on this page, as of the latest one.
Is Abinand Rangesh buying or selling?
In the last 12 months Abinand Rangesh reported 1 open-market buy worth $6,894 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $6,894 of TGEN on Mar 20, 2026. Grants, option exercises and tax withholding are not counted.
How did Abinand Rangesh's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Abinand Rangesh has 0.
Where does Abinand Rangesh file Form 4?
Abinand Rangesh has filed Form 4 at TGEN (TECOGEN INC.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.